Market LIVE
Published markets; coverage varies by country
Product profile · United States

EMPAVELI

 ·  Patent Litigation & Settlement History ↓

IngredientPEGCETACOPLAN
Application typeNDA
Application215014
Product001
Dosage formSOLUTION
RouteSUBCUTANEOUS
Strength1080MG/20ML (54MG/ML)
Approval date2021-05-14
Marketing statusPrescription
Status event—
ApplicantAPELLIS PHARMS
Product source

Current GenericRadar decision

Year2033
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2033-11-15
Patent anchor2033-11-15
Exclusivity anchor2026-05-14
Protection date2038-12-14
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2033. Anchor type: PATENT. Patent anchor: 2033-11-15. Exclusivity anchor: 2026-05-14. Anchor date: 2033-11-15. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
91693072027-11-18DS/U U-4244YNTRUE_DS
English description not available.
———
91693072027-11-18DS/U U-3123YNTRUE_DS
English description not available.
———
91693072027-11-18ORANGE_BOOK U-3123;U-4244YNTRUE_DS
English description not available.
———
78883232027-12-04DS —YNTRUE_DS
English description not available.
———
78883232027-12-04ORANGE_BOOK —YNTRUE_DS
English description not available.
———
79895892027-12-04DS —YNTRUE_DS
English description not available.
———
79895892027-12-04ORANGE_BOOK —YNTRUE_DS
English description not available.
———
116614412033-01-13DS/U U-4242NYU
English description not available.
———
116614412033-01-13DS/U U-3124NYU
English description not available.
———
116614412033-01-13ORANGE_BOOK U-3124;U-4242NYU
English description not available.
———
101251712033-08-02DS —YNTRUE_DS
English description not available.
———
101251712033-08-02ORANGE_BOOK —YNTRUE_DS
English description not available.
———
100358222033-11-15DS —YNTRUE_DS
English description not available.
———
100358222033-11-15ORANGE_BOOK —YNTRUE_DS
English description not available.
———
108758932033-11-15DS/U U-4242YNTRUE_DS
English description not available.
———
108758932033-11-15DS/U U-3124YNTRUE_DS
English description not available.
———
108758932033-11-15ORANGE_BOOK U-3124;U-4242YNTRUE_DS
English description not available.
———
112928152033-11-15DS/DP/U U-4242YNTRUE_DS
English description not available.
———
112928152033-11-15DS/DP/U U-4243YNTRUE_DS
English description not available.
———
112928152033-11-15DS/DP/U U-3124YNTRUE_DS
English description not available.
———
112928152033-11-15DS/DP/U U-3354YNTRUE_DS
English description not available.
———
112928152033-11-15ORANGE_BOOK U-3124;U-3354;U-4242;U-4243YNTRUE_DS
English description not available.
———
110401072038-04-09DP/U U-4241NNU
English description not available.
———
110401072038-04-09DP/U U-3173NNU
English description not available.
———
110401072038-04-09DP/U U-3174NNU
English description not available.
———
110401072038-04-09DP/U U-3172NNU
English description not available.
———
110401072038-04-09ORANGE_BOOK U-3172;U-3173;U-3174;U-4241NNU
English description not available.
———
118448412038-12-09DP/U U-3173NNU
English description not available.
———
118448412038-12-09DP/U U-3172NNU
English description not available.
———
118448412038-12-09DP/U U-4241NNU
English description not available.
———
118448412038-12-09DP/U U-3174NNU
English description not available.
———
118448412038-12-09ORANGE_BOOK U-3172;U-3173;U-3174;U-4241NNU
English description not available.
———
122905662038-12-14DP/U U-4175NNDP
English description not available.
———
122905662038-12-14DP/U U-4174NNDP
English description not available.
———
122905662038-12-14DP/U U-4238NNDP
English description not available.
———
122905662038-12-14DP/U U-4240NNDP
English description not available.
———
122905662038-12-14DP/U U-4239NNDP
English description not available.
———
122905662038-12-14ORANGE_BOOK U-4174;U-4175;U-4238;U-4239;U-4240NNDP
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
M-2882023-02-082026-02-08English description not available.NN——Source
M-2882023-02-082026-02-08English description not available.NN—
NCE
Full coverage date: —
Source
NCE2021-05-142026-05-14English description not available.YY2026-05-14—Source
NCE2021-05-142026-05-14English description not available.YY2026-05-14
NCE
Full coverage date: 2026-05-14
Source
ODE-3512021-05-142028-05-14English description not available.NN——Source
ODE-3512021-05-142028-05-14English description not available.NN—
NCE
Full coverage date: —
Source
I-9722025-07-282028-07-28English description not available.NN——Source
I-9722025-07-282028-07-28English description not available.NN—
NCE
Full coverage date: —
Source
ODE-5332025-07-282032-07-28English description not available.NN——Source
ODE-5332025-07-282032-07-28English description not available.NN—
NCE
Full coverage date: —
Source
ODE-5392025-07-282032-07-28English description not available.NN——Source
ODE-5392025-07-282032-07-28English description not available.NN—
NCE
Full coverage date: —
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (18)
TypeDateRoleBasisSource
PATENT2027-11-18HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2027-12-04HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2027-12-04HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-01-13HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-08-02HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-11-15CANONICAL_ANCHOREnglish description not available.Source
PATENT2033-11-15CANONICAL_ANCHOREnglish description not available.Source
PATENT2033-11-15CANONICAL_ANCHOREnglish description not available.Source
PATENT2038-04-09FTO_TAILEnglish description not available.Source
PATENT2038-12-09FTO_TAILEnglish description not available.Source
PATENT2038-12-14FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2033-11-15CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.